cerca CERCA
Venerdì 06 Dicembre 2024
Aggiornato: 18:47
10 ultim'ora BREAKING NEWS

PR NEWSWIRE

comunicato stampa

Bitget: La Proof of Reserves di Novembre Mostra la Crescita Più Elevata del 2024

VICTORIA, Seychelles, 6 dicembre 2024 /PRNewswire/ -- Bitget, società Web3 ed uno dei principali exchange di criptovalute, ha pubblicato l'aggiornamento mensile della sua Proof-of-Reserves. A novembre, i dati mostrano che le riserve di Bitget sono aumentate in tutte le principali classi di asset detenute dagli utenti, mostrando una crescente fiducia e coinvolgimento nella piattaforma.

comunicato stampa

EliTe Solar Commissions High-Efficiency Solar Cell Production Facility in Indonesia

BATAM, Indonesia, Dec. 6, 2024 /PRNewswire/ -- On December 4, 2024, EliTe Solar successfully commissioned its high-efficiency solar cell production facility in Indonesia. This achievement represents a significant step in EliTe Solar's global expansion and underscores the company's commitment to optimizing Indonesia's energy landscape, promoting clean energy adoption, and driving economic and social development in the region.

comunicato stampa

CMG's Video Media Forum aims to advance collaboration, amplify voices of Global South

BEIJING, Dec. 6, 2024 /PRNewswire/ -- The 12th Global Video Media Forum (VMF), which opened in Quanzhou City of east China'sFujian Province on Tuesday, has yielded many significant outcomes including the release of a joint initiative and media cooperation mechanism which aims to boost exchanges and enhance the voice of the Global South.

comunicato stampa

BC.GAME CONTINUES ONGOING EFFORTS IN STRENGTHENING ITS GLOBAL COMPLIANCE STRATEGY

NICOSIA, Cyprus, Dec. 5, 2024 /PRNewswire/ -- BC.GAME, a premier cryptocurrency i-Gaming platform, announced its decision to withdraw its license specifically from Curaçao. This move reflects Curaçao's increasingly hostile environment for operators in recent years. Despite ongoing efforts to modernize Curaçao's i-Gaming law, proper legal protection for all operators established in Curaçao is severely lacking, such as its bankruptcy law which dates to 1931 via the "Curaçao Bankruptcy Decree" which...

comunicato stampa

Moove Partners with Waymo to Redefine the Future of Urban Mobility

DUBAI, UAE, Dec. 5, 2024 /PRNewswire/ -- Moove, a global leader in innovative mobility solutions, is proud to announce a groundbreaking fleet partnership with Waymo, the global leader in autonomous driving technology. This collaboration represents the first commercial partnership of its kind on the Waymo One app.

comunicato stampa

Path Seekers: Embarking on a Journey to Explore Civilization

NANJING, China, Dec. 5, 2024 /PRNewswire/ -- This is a news report from JICC: China's renowned ancient paths are not merely historical records etched into the land—they are living embodiments of evolving modern civilization. These cultural arteries preserve the threads of traditional Chinese heritage, chronicle exchanges with other cultures, and link ancient, contemporary, and future China.

comunicato stampa

AtomVie Global Radiopharma Appoints Dr. Pratibhash Chattopadhyay as Chief Business Officer to Accelerate Growth and Strengthen Leadership

HAMILTON, ON, Dec. 5, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, is pleased to announce the appointment of Dr. Pratibhash (Bosh) Chattopadhyay as Chief Business Officer. Dr. Chattopadhyay brings over 25 years of commercial and technical expertise in the life sciences, having led numerous commercialization initiatives for pioneering technologies in oncology. His expertise spans multiple pharmaceutical sectors, including contract developmen...

comunicato stampa

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

CARDIFF-BY-THE-SEA, Calif., Dec. 5, 2024 /PRNewswire/ -- Field Medical® Inc., a leader in pulsed field cardiac catheter ablation technology, announced today that its FieldForce™ Ablation System has been accepted into the FDA's Total Product Life Cycle Advisory Program (TAP) Pilot and granted Breakthrough Device Designation for sustained monomorphic scar-related ventricular tachycardia (VT). This recognition underscores the system's groundbreaking approach to addressing life-threatening VT and the...

comunicato stampa

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a multicentre, randomized, blinded-assessor, phase II non-inferiority study evaluating the efficacy and tolerability of NTC014 (quinolone antibiotic + NSAID in eye drops solution) in the treatment of bacterial conjunctivitis in adults.



SEGUICI SUI SOCIAL



threads whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
articoli
in Evidenza